GAP INNOVATIONS
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

GAP INNOVATIONS Trademark

Serial Number: 98116918

GAP INNOVATIONS is a trademark filed by Global Alzheimer's Platform Foundation Inc. on August 4, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Global Alzheimer's Platform Foundation Inc. (15 trademarks)

1101 K Street NW, Suite 400
Washington, DC 20005

Entity Type: 03

Trademark Details

Filing Date

August 4, 2023

Registration Date

Not Registered

Published for Opposition

March 18, 2025

Goods & Services

Scientific research in the nature of conducting clinical trials and research for others in the field of Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Medical and scientific research, namely, conducting clinical trials for others; Medical and scientific research, namely, conducting clinical trials for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases

Healthcare services, namely, administering care to patients; Healthcare services, namely, administering care to patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Healthcare services, namely, administering tests for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Healthcare services, namely, taking samples from patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Establishing a blood bank of biological samples related to Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Providing health screening services in the field of Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Providing health screening services related to Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 28, 2026 EXRA
SOU EXTENSION 1 GRANTED
Feb 27, 2026 EX1G
SOU EXTENSION 1 FILED
Feb 27, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 27, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 2, 2025 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jul 27, 2025 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Apr 2, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 12, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 24, 2025 CNSA
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 7, 2024 GNFN
FINAL REFUSAL E-MAILED
Nov 7, 2024 GNFR
FINAL REFUSAL WRITTEN
Nov 7, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 8, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 8, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 9, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 9, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 10, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 10, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 10, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 5, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2023 NWOS
NEW APPLICATION ENTERED
Aug 8, 2023 NWAP